Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel Free XNCR Stock Alerts

Xencor (XNCR) News Today

Xencor logo
$27.80 +0.80 (+2.96%)
As of 08/21/2026 04:00 PM Eastern
Compare

Xencor Latest News

103,736 Shares in Xencor, Inc. $XNCR Bought by DCF Advisers LLC
August 20 at 4:16 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-103736-shares-in-xencor-inc-xncr-bought-by-dcf-advisers-llc-2026-08-20/
Xencor (NASDAQ:XNCR) Sets New 52-Week High - Should You Buy?
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-sets-new-52-week-high-should-you-buy-2026-08-18/
Johnson & Johnson Purchases New Shares in Xencor, Inc. $XNCR
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-johnson-johnson-purchases-new-shares-in-xencor-inc-xncr-2026-08-16/
Xencor, Inc. (XNCR) Stock Major Holders - Yahoo Finance
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/XNCR/holders/
Xencor (NASDAQ:XNCR) Hits New 1-Year High - Here's What Happened
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-hits-new-1-year-high-heres-what-happened-2026-08-12/
Analysts Offer Insights on Healthcare Companies: Xencor (XNCR), Alpha Teknova (TKNO) and Solventum Corporation (SOLV)
August 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR-Q/pressreleases/3713467/analysts-offer-insights-on-healthcare-companies-xencor-xncr-alpha-teknova-tkno-and-solventum-corporation-solv/
Xencor (NASDAQ:XNCR) Stock Rating Upgraded by Wall Street Zen
August 8, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-stock-rating-upgraded-by-wall-street-zen-2026-08-08/
Xencor: Q2 Earnings Snapshot
August 7, 2026  |  sfgate.comhttps://www.sfgate.com/business/article/xencor-q2-earnings-snapshot-22375931.php
RBC Capital Sticks to Their Buy Rating for Xencor (XNCR)
August 7, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR/pressreleases/3715812/rbc-capital-sticks-to-their-buy-rating-for-xencor-xncr/
Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Hold" by Brokerages
August 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-inc-nasdaqxncr-given-consensus-recommendation-of-hold-by-brokerages-2026-08-07/
Xencor (NASDAQ:XNCR) Price Target Raised to $30.00
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-price-target-raised-to-3000-2026-08-06/
Xencor (NASDAQ:XNCR) Hits New 52-Week High Following Better-Than-Expected Earnings
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-hits-new-52-week-high-following-better-than-expected-earnings-2026-08-06/
Xencor (NASDAQ:XNCR) Price Target Raised to $44.00 at Cantor Fitzgerald
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-price-target-raised-to-4400-at-cantor-fitzgerald-2026-08-06/
Xencor (NASDAQ:XNCR) Releases Earnings Results, Beats Expectations By $0.51 EPS
August 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-releases-earnings-results-beats-expectations-by-051-eps-2026-08-05/
Xencor (NASDAQ:XNCR) Trading Down 3.9% - Here's Why
August 3, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-trading-down-39-heres-why-2026-08-03/
Xencor’s XmAb412 Enters First-in-Human Testing: What Early-Stage Investors Should Watch
August 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/xencors-xmab412-enters-first-in-human-testing-what-early-stage-investors-should-watch?utm_source=marketbeat.com&utm_medium=referral
Xencor (NASDAQ:XNCR) Reaches New 1-Year High - Should You Buy?
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-nasdaqxncr-reaches-new-1-year-high-should-you-buy-2026-07-30/
Wedbush Reiterates Outperform Rating for Xencor (NASDAQ:XNCR)
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wedbush-reiterates-outperform-rating-for-xencor-nasdaqxncr-2026-07-30/
Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter
July 29, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/xencor-receive-105-million-alexion-200100195.html
Xencor (XNCR) Expected to Post Earnings on Wednesday
July 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/xencor-xncr-expected-to-post-earnings-on-wednesday-2026-07-29/
EcoR1 Capital LLC Cuts Stock Holdings in Xencor, Inc. $XNCR
July 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-ecor1-capital-llc-cuts-stock-holdings-in-xencor-inc-xncr-2026-07-28/
Xencor: Strong Buy, XmAb819 Presentation, And End Of 2026 XmAb942 Interim Data
July 19, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4923333-xencor-strong-buy-xmab819-presentation-and-end-of-2026-xmab942-interim-data
Xencor Inc.
July 17, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/XNCR/financials/cash-flow
Xencor advances 17% after revealing ESMO 2026 oral presentation slot
July 17, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4615067-xencor-advances-17-after-revealing-esmo-2026-oral-presentation-slot
Xencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
July 17, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260716029119/en/xencor-announces-proffered-paper-oral-presentation-at-esmo-2026-for-phase-1-clinical-study-of-xmab819-in-advanced-clear-cell-renal-cell-carcinoma/
Xencor: Bullish On Their Increasingly In-House Pipeline
July 14, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4922052-xencor-bullish-on-their-increasingly-in-house-pipeline
Xencor Updates Outlook Amid Ultomiris Royalty Dispute
June 19, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR-Q/pressreleases/594951/xencor-updates-outlook-amid-ultomiris-royalty-dispute/
Xencor Shareholders Approve Directors, Incentive Plan Amendments
June 18, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/xencor-shareholders-approve-directors-incentive-plan-amendments?utm_source=marketbeat.com&utm_medium=referral
Xencor (XNCR) Stock Draws Fresh Price Target Split As Pipeline Progress Meets Caution
June 15, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/xencor-xncr-stock-draws-fresh-051132610.html
Incyte lymphoma therapy lifts cancer-free survival by 25% in late-stage trial
May 30, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4598637-incyte-lymphoma-therapy-lifts-cancer-free-survival-25
Xencor Inc
May 18, 2026  |  money.usnews.comhttps://money.usnews.com/investing/stocks/xncr-xencor-inc/vitals
Xencor (XNCR) Receives a Buy from Wells Fargo
May 15, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR/pressreleases/1798784/xencor-xncr-receives-a-buy-from-wells-fargo/
Xencor, Inc. Common Stock (XNCR)
May 13, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/xncr/analyst-research
Xencor, Inc. (XNCR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
May 13, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4903629-xencor-inc-xncr-presents-at-bank-of-america-global-healthcare-conference-2026-transcript
These Analysts Think Xencor, Inc.'s (NASDAQ:XNCR) Sales Are Under Threat
May 8, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/analysts-think-xencor-inc-nasdaq-111142363.html
Xencor Reports First Quarter 2026 Financial Results
May 6, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260506934755/en/xencor-reports-first-quarter-2026-financial-results/
Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 Transcript
May 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4898753-xencor-inc-xncr-discusses-phase-i-results-for-xmab942-and-preclinical-data-for-xmab412
Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412 - Slideshow
May 5, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4898755-xencor-inc-xncr-discusses-phase-i-results-for-xmab942-and-preclinical-data-for-xmab412
Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW
May 4, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260504721570/en/xencor-to-host-webcast-to-discuss-xmab942-and-xmab412-data-presentations-at-ddw/
JP Morgan Downgrades Xencor (XNCR)
March 25, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/jp-morgan-downgrades-xencor-xncr/ar-AA1Zlttc
Xencor (XNCR) Receives a Buy from Wedbush
March 17, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/XNCR/pressreleases/607730/xencor-xncr-receives-a-buy-from-wedbush/
Xencor, Inc. (XNCR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
March 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4881189-xencor-inc-xncr-presents-at-barclays-28th-annual-global-healthcare-conference-transcript
Xencor (NASDAQ:XNCR) SVP Sells $19,472.34 in Stock
March 10, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-xncr-insider-buying-and-selling-2026-03-10/
Xencor, Genentech to End Protein Therapeutics Collaboration
March 9, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/xencor-genentech-to-end-protein-therapeutics-collaboration?utm_source=marketbeat.com&utm_medium=referral
Xencor (NASDAQ:XNCR) SVP Sells $17,754.80 in Stock
March 5, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-xncr-insider-buying-and-selling-2026-03-05/
Royalty Rift: Alexion Cuts Off US Royalty Payments To Xencor
March 5, 2026  |  benzinga.comhttps://www.benzinga.com/news/health-care/26/03/51060353/royalty-rift-alexion-cuts-off-us-royalty-payments-to-xencor
Xencor Announces Change to Ultomiris® Royalty Revenue Forecast
March 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/xencor-announces-change-ultomiris-royalty-210100262.html
Xencor Reports Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260225902842/en/xencor-reports-fourth-quarter-and-full-year-2025-financial-results/
What Catalysts Are Rewriting The Xencor (XNCR) Story In A Recovering Biopharma Sector
February 9, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/catalysts-rewriting-xencor-xncr-story-231143082.html
Xencor (XNCR): BofA Bullish on US Biopharmaceuticals Coverage
January 29, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/blog/xencor-xncr-bofa-bullish-on-us-biopharmaceuticals-coverage-1683738/

Xencor Media Mentions By Week

Xencor Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

XNCR
News Sentiment
▼
1.04

0.65
▲
Average
Healthcare
News Sentiment

Xencor News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

XNCR Articles
This Week
▼
2

3
▲
XNCR Articles
Average Week

Xencor Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
3
+200%
Page Views
1,673
+2%
Get Xencor News Delivered to You Automatically

Sign up to receive the latest news and ratings for XNCR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools

Related Companies
News and Trends Tools

This page (NASDAQ:XNCR) was last updated on 8/23/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel